{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T01:03:12Z","timestamp":1782867792779,"version":"3.54.5"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T00:00:00Z","timestamp":1681862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T00:00:00Z","timestamp":1681862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI16\/2053"],"award-info":[{"award-number":["PI16\/2053"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI21\/1119"],"award-info":[{"award-number":["PI21\/1119"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI21\/132"],"award-info":[{"award-number":["PI21\/132"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI21\/01642"],"award-info":[{"award-number":["PI21\/01642"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002655","name":"Beckman Coulter Foundation","doi-asserted-by":"publisher","award":["PI21\/132"],"award-info":[{"award-number":["PI21\/132"]}],"id":[{"id":"10.13039\/100002655","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s10875-023-01488-6","type":"journal-article","created":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T11:02:16Z","timestamp":1681902136000},"page":"1278-1288","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Inborn Error of STAT2-Dependent IFN-I Immunity in a Patient Presented with Hemophagocytic Lymphohistiocytosis and Multisystem Inflammatory Syndrome in Children"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1236-9281","authenticated-orcid":false,"given":"Marta","family":"L\u00f3pez-Nevado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juli\u00e1n","family":"Sevilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Almendro-V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco J.","family":"Gil-Etayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Garcinu\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Serrano-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estela","family":"Paz-Artal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis I.","family":"Gonz\u00e1lez-Granado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis M.","family":"Allende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,19]]},"reference":[{"issue":"2","key":"1488_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nri3787","volume":"15","author":"F McNab","year":"2015","unstructured":"McNab F, Mayer-Barber K, Sher A, Wack A, O\u2019Garra A. Type I interferons in infectious disease. Nat Rev Immunol. 2015;15(2):87\u2013103 (Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/25614319\/).","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"1488_CR2","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/s41435-020-00116-2","volume":"21","author":"M Bourdon","year":"2020","unstructured":"Bourdon M, Manet C, Montagutelli X. Host genetic susceptibility to viral infections: the role of type I interferon induction. Genes Immun. 2020;21(6):365\u201379.","journal-title":"Genes Immun"},{"key":"1488_CR3","doi-asserted-by":"crossref","unstructured":"Tangye SG, Al-Herz W, Bousfiha A, Cunningham-Rundles C, Franco JL, Holland SM, et al. Human inborn errors of immunity: 2022 update on the classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2022. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35748970\/. Retrieved October 21 2022 from: https:\/\/link.springer.com\/article\/10.1007\/s10875-022-01289-3.","DOI":"10.1007\/s10875-022-01289-3"},{"key":"1488_CR4","doi-asserted-by":"crossref","unstructured":"Bousfiha A, Moundir A, Tangye SG, Picard C, Jeddane L, Al-Herz W, et al. The 2022 update of IUIS phenotypical classification for human inborn errors of immunity. J Clin Immunol. 2022;42(7). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/36198931\/.\u00a0Retrieved October 21, 2022, from:\u00a0https:\/\/link.springer.com\/article\/10.1007\/s10875-022-01352-z.","DOI":"10.1007\/s10875-022-01352-z"},{"issue":"2","key":"1488_CR5","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.jaci.2018.07.013","volume":"143","author":"G Bucciol","year":"2019","unstructured":"Bucciol G, Moens L, Bosch B, Bossuyt X, Casanova JL, Puel A, et al. Lessons learned from the study of human inborn errors of innate immunity. J Allergy Clin Immunol. 2019;143(2):507\u201327. https:\/\/doi.org\/10.1016\/j.jaci.2018.07.013.","journal-title":"J Allergy Clin Immunol"},{"key":"1488_CR6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.coi.2019.12.002","volume":"62","author":"L Moens","year":"2020","unstructured":"Moens L, Meyts I. Recent human genetic errors of innate immunity leading to increased susceptibility to infection. Curr Opin Immunol. 2020;62:79\u201390 (Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31935567\/).","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"1488_CR7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1182\/blood-2017-11-814244","volume":"132","author":"IK Chinn","year":"2018","unstructured":"Chinn IK, Eckstein OS, Peckham-Gregory EC, Goldberg BR, Forbes LR, Nicholas SK, et al. Genetic and mechanistic diversity in pediatric hemophagocytic lymphohistiocytosis. Blood. 2018;132(1):89\u2013100 (Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29632024\/).","journal-title":"Blood"},{"key":"1488_CR8","doi-asserted-by":"crossref","unstructured":"Imashuku S, Morimoto A, Ishii E. Virus-triggered secondary hemophagocytic lymphohistiocytosis. Acta Paediatr. 2021;110(10):2729\u201336.","DOI":"10.1111\/apa.15973"},{"issue":"8","key":"1488_CR9","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1073\/pnas.1220098110","volume":"110","author":"S Hambleton","year":"2013","unstructured":"Hambleton S, Goodbourn S, Young DF, Dickinson P, Mohamad SMB, Valappil M, et al. STAT2 deficiency and susceptibility to viral illness in humans. Proc Natl Acad Sci U S A. 2013;110(8):3053\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Pt 10","key":"1488_CR10","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1093\/brain\/awv182","volume":"138","author":"R Shahni","year":"2015","unstructured":"Shahni R, Cale CM, Anderson G, Osellame LD, Hambleton S, Jacques TS, et al. Signal transducer and activator of transcription 2 deficiency is a novel disorder of mitochondrial fission. Brain. 2015;138(Pt 10):2834\u201346 (Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26122121\/).","journal-title":"Brain"},{"issue":"6","key":"1488_CR11","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1016\/j.jaci.2016.10.033","volume":"139","author":"L Moens","year":"2017","unstructured":"Moens L, Van Eyck L, Jochmans D, Mitera T, Frans G, Bossuyt X, et al. A novel kindred with inherited STAT2 deficiency and severe viral illness. J Allergy Clin Immunol. 2017;139(6):1995-1997.e9.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"1488_CR12","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.jaci.2019.05.008","volume":"144","author":"MF Alosaimi","year":"2019","unstructured":"Alosaimi MF, Maciag MC, Platt CD, Geha RS, Chou J, Bartnikas LM. A novel variant in STAT2 presenting with hemophagocytic lymphohistiocytosis. J Allergy Clin Immunol. 2019;144(2):611-613.e3.","journal-title":"J Allergy Clin Immunol"},{"issue":"February","key":"1488_CR13","first-page":"1","volume":"11","author":"BJ Freij","year":"2021","unstructured":"Freij BJ, Hanrath AT, Chen R, Hambleton S, Duncan CJA. Life-threatening influenza, hemophagocytic lymphohistiocytosis and probable vaccine-strain varicella in a novel case of homozygous STAT2 deficiency. Front Immunol. 2021;11(February):1\u20139.","journal-title":"Front Immunol"},{"key":"1488_CR14","doi-asserted-by":"crossref","unstructured":"Bucciol G, Moens L, Ogishi M, Rinchai D, Matuozzo D, Momenilandi M, et al. Human inherited complete STAT2 deficiency underlies inflammatory viral diseases. J Clin Invest. 2023; Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/36976641\/. Retrieved April 04, 2023 from https:\/\/www.jci.org\/articles\/view\/168321.","DOI":"10.1172\/JCI168321"},{"key":"1488_CR15","unstructured":"Gothe F, Stremenova Spegarova J, Hatton CF, Griffin H, Sargent T, Cowley SA, et al. Aberrant inflammatory responses to type I interferon in STAT2 or IRF9 deficiency. J Allergy Clin Immunol. 2022; Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35182547\/. Retrieved November 2022 from https:\/\/www.jacionline.org\/article\/S0091-6749(22)00185-3\/fulltext."},{"issue":"1","key":"1488_CR16","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1093\/cid\/ciaa1790","volume":"74","author":"F Gothe","year":"2022","unstructured":"Gothe F, Hatton CF, Truong L, Klimova Z, Kanderova V, Fejtkova M, et al. A novel case of homozygous interferon alpha\/beta receptor alpha chain (IFNAR1) deficiency with hemophagocytic lymphohistiocytosis. Clin Infect Dis. 2022;74(1):136\u20139 (Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33252644\/).","journal-title":"Clin Infect Dis"},{"issue":"September","key":"1488_CR17","first-page":"1","volume":"11","author":"C Passarelli","year":"2020","unstructured":"Passarelli C, Civino A, Rossi MN, Cifaldi L, Lanari V, Moneta GM, et al. IFNAR2 deficiency causing dysregulation of NK cell functions and presenting with hemophagocytic lymphohistiocytosis. Front Genet. 2020;11(September):1\u20136.","journal-title":"Front Genet"},{"issue":"9","key":"1488_CR18","doi-asserted-by":"publisher","first-page":"3102","DOI":"10.1016\/j.jaip.2020.06.034","volume":"8","author":"DFR Boehmer","year":"2020","unstructured":"Boehmer DFR, Koehler LM, Magg T, Metzger P, Rohlfs M, Ahlfeld J, et al. A novel complete autosomal-recessive STAT1 LOF variant causes immunodeficiency with hemophagocytic lymphohistiocytosis-like hyperinflammation. J allergy Clin Immunol Pract. 2020;8(9):3102\u201311 (Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32603902\/).","journal-title":"J allergy Clin Immunol Pract"},{"issue":"4","key":"1488_CR19","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.jaip.2016.02.015","volume":"4","author":"C Burns","year":"2016","unstructured":"Burns C, Cheung A, Stark Z, Choo S, Downie L, White S, et al. A novel presentation of homozygous loss-of-function STAT-1 mutation in an infant with hyperinflammation-a case report and review of the literature. J allergy Clin Immunol Pract. 2016;4(4):777\u20139 (Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/27117246\/).","journal-title":"J allergy Clin Immunol Pract"},{"issue":"10","key":"1488_CR20","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1093\/intimm\/dxaa043","volume":"32","author":"S Sakata","year":"2020","unstructured":"Sakata S, Tsumura M, Matsubayashi T, Karakawa S, Kimura S, Tamaura M, et al. Autosomal recessive complete STAT1 deficiency caused by compound heterozygous intronic mutations. Int Immunol. 2020;32(10):663\u201371 (Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32603428\/).","journal-title":"Int Immunol"},{"key":"1488_CR21","doi-asserted-by":"crossref","unstructured":"Billiau A. Anti-inflammatory properties of Type I interferons. Antiviral Res. 2006;71(2\u20133):108\u201316.","DOI":"10.1016\/j.antiviral.2006.03.006"},{"issue":"6","key":"1488_CR22","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.3390\/jcm10061164","volume":"10","author":"I Di Cola","year":"2021","unstructured":"Di Cola I, Ruscitti P, Giacomelli R, Cipriani P. The pathogenic role of interferons in the hyperinflammatory response on adult-onset still\u2019s disease and macrophage activation syndrome: paving the way towards new therapeutic targets. J Clin Med. 2021;10(6):1164.","journal-title":"J Clin Med"},{"issue":"12","key":"1488_CR23","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1038\/s41590-019-0466-2","volume":"20","author":"FJ Barrat","year":"2019","unstructured":"Barrat FJ, Crow MK, Ivashkiv LB. Interferon target-gene expression and epigenomic signatures in health and disease. Nat Immunol. 2019;20(12):1574\u201383 (Available from: https:\/\/www.nature.com\/articles\/s41590-019-0466-2).","journal-title":"Nat Immunol"},{"issue":"2","key":"1488_CR24","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.immuni.2011.02.006","volume":"34","author":"G Guarda","year":"2011","unstructured":"Guarda G, Braun M, Staehli F, Tardivel A, Mattmann C, F\u00f6rster I, et al. Type I interferon inhibits interleukin-1 production and inflammasome activation. Immunity. 2011;34(2):213\u201323.","journal-title":"Immunity"},{"issue":"7","key":"1488_CR25","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1007\/s10875-021-01066-8","volume":"41","author":"ES Goudouris","year":"2021","unstructured":"Goudouris ES, Pinto-Mariz F, Mendon\u00e7a LO, Aranda CS, Guimar\u00e3es RR, Kokron C, et al. Outcome of SARS-CoV-2 infection in 121 patients with inborn errors of immunity: a cross-sectional study. J Clin Immunol. 2021;41(7):1479\u201389 (>Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34164762\/).","journal-title":"J Clin Immunol"},{"issue":"10237","key":"1488_CR26","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/S0140-6736(20)31094-1","volume":"395","author":"S Riphagen","year":"2020","unstructured":"Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020;395(10237):1607\u20138 (Available from: http:\/\/www.thelancet.com\/article\/S0140673620310941\/fulltext).","journal-title":"Lancet"},{"key":"1488_CR27","doi-asserted-by":"crossref","unstructured":"Nakra NA, Blumberg DA, Herrera-Guerra A, Lakshminrusimha S. Multi-system inflammatory syndrome in children (MIS-C) following SARS-CoV-2 infection: review of clinical presentation, hypothetical pathogenesis, and proposed management. Child (Basel, Switzerland). 2020;7(7). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32630212\/. Retrieved January 2022 from https:\/\/www.mdpi.com\/2227-9067\/7\/7\/69.","DOI":"10.3390\/children7070069"},{"key":"1488_CR28","doi-asserted-by":"crossref","unstructured":"Kumar D, Rostad CA, Jaggi P, Villacis Nunez DS, Chengyu Prince, Lu A, et al. Distinguishing immune activation and inflammatory signatures of multisystem inflammatory syndrome in children (MIS-C) versus hemophagocytic lymphohistiocytosis (HLH). J Allergy Clin Immunol. 2022;149(5). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35304157\/. Retrieved June 2022 from https:\/\/www.jacionline.org\/article\/S0091-6749(22)00297-4\/fulltext.","DOI":"10.1016\/j.jaci.2022.02.028"},{"key":"1488_CR29","first-page":"2","volume":"57","author":"J Hui-Yuen","year":"2011","unstructured":"Hui-Yuen J, McAllister S, Koganti S, Hill E, Bhaduri-Mcintosh S. Establishment of Epstein-Barr virus growth-transformed lymphoblastoid cell lines. J Vis Exp. 2011;57:2\u20137.","journal-title":"J Vis Exp"},{"key":"1488_CR30","doi-asserted-by":"crossref","unstructured":"Almendro-V\u00e1zquez P, Laguna-Goya R, Ruiz-Ruigomez M, Utrero-Rico A, Lalueza A, de la Calle GM, et al. Longitudinal dynamics of SARS-CoV-2-specific cellular and humoral immunity after natural infection or BNT162b2 vaccination. PLoS Pathog. 2021;17(12). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34962970\/. Retrieved June 2022 from https:\/\/journals.plos.org\/plospathogens\/article?id=10.1371\/journal.ppat.1010211.","DOI":"10.1371\/journal.ppat.1010211"},{"issue":"2","key":"1488_CR31","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter JI, Horne AC, Aric\u00f3 M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124\u201331 (Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/16937360\/).","journal-title":"Pediatr Blood Cancer"},{"key":"1488_CR32","doi-asserted-by":"crossref","unstructured":"Garcinu\u00f1o S, Gil-Etayo FJ, Mancebo E, L\u00f3pez-Nevado M, Lalueza A, D\u00edaz-Sim\u00f3n R, et al. Effective natural killer cell degranulation is an essential key in COVID-19 evolution. Int J Mol Sci. 2022;23(12). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35743021\/. Retrieved December 2022 from https:\/\/www.mdpi.com\/1422-0067\/23\/12\/6577.","DOI":"10.3390\/ijms23126577"},{"key":"1488_CR33","doi-asserted-by":"crossref","unstructured":"Mogensen TH. IRF and STAT transcription factors - from basic biology to roles in infection, protective immunity, and primary immunodeficiencies. Front Immunol. 2019;8(9):3047.","DOI":"10.3389\/fimmu.2018.03047"},{"issue":"7","key":"1488_CR34","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S0300-9084(02)01431-1","volume":"84","author":"A Civas","year":"2002","unstructured":"Civas A, Island ML, G\u00e9nin P, Morin P, Navarro S. Regulation of virus-induced interferon-A genes. Biochimie. 2002;84(7):643\u201354.","journal-title":"Biochimie"},{"issue":"5","key":"1488_CR35","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.jaci.2016.12.978","volume":"140","author":"A Fischer","year":"2017","unstructured":"Fischer A, Provot J, Jais JP, Alcais A, Mahlaoui N, Adoue D, et al. Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies. J Allergy Clin Immunol. 2017;140(5):1388-1393.e8 (Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/28192146\/).","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"1488_CR36","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1002\/eji.202048793","volume":"51","author":"I Meyts","year":"2021","unstructured":"Meyts I, Casanova JL. Viral infections in humans and mice with genetic deficiencies of the type I IFN response pathway. Eur J Immunol. 2021;51(5):1039\u201361.","journal-title":"Eur J Immunol"},{"issue":"3","key":"1488_CR37","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s10875-022-01215-7","volume":"42","author":"H Abolhassani","year":"2022","unstructured":"Abolhassani H, Landegren N, Bastard P, Materna M, Modaresi M, Du L, et al. Inherited IFNAR1 deficiency in a child with both critical COVID-19 pneumonia and multisystem inflammatory syndrome. J Clin Immunol. 2022;42(3):471\u201383 (Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35091979\/).","journal-title":"J Clin Immunol"},{"issue":"4","key":"1488_CR38","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1056\/NEJMoa2021680","volume":"383","author":"LR Feldstein","year":"2020","unstructured":"Feldstein LR, Rose EB, Horwitz SM, Collins JP, Newhams MM, Son MBF, et al. Multisystem inflammatory syndrome in U.S. children and adolescents. N Engl J Med. 2020;383(4):334\u201346 (Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32598831\/).","journal-title":"N Engl J Med"},{"key":"1488_CR39","doi-asserted-by":"crossref","unstructured":"Giardino G, Milito C, Lougaris V, Punziano A, Carrabba M, Cinetto F, et al. The impact of SARS-CoV-2 infection in patients with inborn errors of immunity: the experience of the Italian Primary Immunodeficiencies Network (IPINet). J Clin Immunol. 2022; Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35445287\/. Retrieved December 2022 from https:\/\/link.springer.com\/article\/10.1007\/s10875-022-01264-y.","DOI":"10.1007\/s10875-022-01264-y"},{"issue":"5","key":"1488_CR40","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.jaci.2020.07.033","volume":"146","author":"PY Lee","year":"2020","unstructured":"Lee PY, Platt CD, Weeks S, Grace RF, Maher G, Gauthier K, et al. Immune dysregulation and multisystem inflammatory syndrome in children (MIS-C) in individuals with haploinsufficiency of SOCS1. J Allergy Clin Immunol. 2020;146(5):1194-1200.e1 (Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32853638\/).","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"1488_CR41","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/nri3133","volume":"12","author":"JM Gonz\u00e1lez-Navajas","year":"2012","unstructured":"Gonz\u00e1lez-Navajas JM, Lee J, David M, Raz E. Immunomodulatory functions of type I interferons. Nat Rev Immunol. 2012;12(2):125\u201335 (Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/22222875\/).","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"1488_CR42","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nri3806","volume":"15","author":"J Crouse","year":"2015","unstructured":"Crouse J, Kalinke U, Oxenius A. Regulation of antiviral T cell responses by type I interferons. Nat Rev Immunol. 2015;15(4):231\u201342 (Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/25790790\/).","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"1488_CR43","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.chom.2016.01.007","volume":"19","author":"R Channappanavar","year":"2016","unstructured":"Channappanavar R, Fehr AR, Vijay R, Mack M, Zhao J, Meyerholz DK, et al. Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice. Cell Host Microbe. 2016;19(2):181\u201393 (Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26867177\/).","journal-title":"Cell Host Microbe"},{"key":"1488_CR44","doi-asserted-by":"crossref","unstructured":"Davidson S, Crotta S, McCabe TM, Wack A. Pathogenic potential of interferon \u03b1\u03b2 in acute influenza infection. Nat Commun. 2014;5. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/24844667\/. Retrieved February 2022 from https:\/\/www.nature.com\/articles\/ncomms4864.","DOI":"10.1038\/ncomms4864"},{"issue":"3","key":"1488_CR45","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/ni.2229","volume":"13","author":"N Yan","year":"2012","unstructured":"Yan N, Chen ZJ. Intrinsic antiviral immunity. Nat Immunol. 2012;13(3):214-22 Available (from: https:\/\/pubmed.ncbi.nlm.nih.gov\/22344284\/).","journal-title":"Nat Immunol"},{"issue":"6504","key":"1488_CR46","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1126\/science.abc6027","volume":"369","author":"J Hadjadj","year":"2020","unstructured":"Hadjadj J, Yatim N, Barnabei L, Corneau A, Boussier J, Smith N, et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science. 2020;369(6504):718\u201324.","journal-title":"Science"},{"key":"1488_CR47","unstructured":"Zhang Q, Bastard P, Liu Z, Pen J Le, Moncada-Velez M, Chen J, et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science 2020;370(6515). Available from: https:\/\/science.sciencemag.org\/content\/370\/6515\/eabd4570. Retrieved October 2020 from https:\/\/www.science.org\/doi\/10.1126\/science.abd4570."},{"issue":"49","key":"1488_CR48","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1126\/sciimmunol.abd1554","volume":"5","author":"JS Lee","year":"2020","unstructured":"Lee JS, Park S, Jeong HW, Ahn JY, Choi SJ, Lee H, et al. Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19. Sci Immunol. 2020;5(49):1554 (Available from: https:\/\/immunology.sciencemag.org\/content\/5\/49\/eabd1554).","journal-title":"Sci Immunol"},{"key":"1488_CR49","unstructured":"Bastard P, Rosen LB, Zhang Q, Michailidis E, Hoffmann H-H, Zhang Y, et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020;370(6515). Available from: https:\/\/science.sciencemag.org\/content\/370\/6515\/eabd4585. Retrieved October 2020 from https:\/\/www.science.org\/doi\/10.1126\/science.abd4585."},{"key":"1488_CR50","doi-asserted-by":"crossref","unstructured":"Contoli M, Papi A, Tomassetti L, Rizzo P, Vieceli Dalla Sega F, Fortini F, et al. Blood interferon-\u03b1 levels and severity, outcomes, and inflammatory profiles in hospitalized COVID-19 patients. Front Immunol. 2021;12. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33767713\/. Retrieved December 2021 from https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.648004\/full.","DOI":"10.3389\/fimmu.2021.648004"},{"key":"1488_CR51","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1126\/sciimmunol.abp8966","volume":"19","author":"P Bastard","year":"2022","unstructured":"Bastard P, Vazquez S, Liu J, Laurie MT, Wang CY, Gervais A, et al. Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs. Sci Immunol. 2022;19:25. https:\/\/doi.org\/10.1126\/sciimmunol.abp8966.","journal-title":"Sci Immunol"},{"issue":"4","key":"1488_CR52","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.it.2021.02.003","volume":"42","author":"C King","year":"2021","unstructured":"King C, Sprent J. Dual nature of type I interferons in SARS-CoV-2-induced inflammation. Trends Immunol. 2021;42(4):312\u201322 (Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33622601\/).","journal-title":"Trends Immunol"},{"issue":"7","key":"1488_CR53","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1007\/s10875-021-01118-z","volume":"41","author":"CJA Duncan","year":"2021","unstructured":"Duncan CJA, Hambleton S. Human disease phenotypes associated with loss and gain of function mutations in STAT2: viral susceptibility and type I interferonopathy. J Clin Immunol. 2021;41(7):1446\u201356 (Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34448086\/).","journal-title":"J Clin Immunol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-023-01488-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-023-01488-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-023-01488-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T04:05:51Z","timestamp":1744171551000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-023-01488-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,19]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["1488"],"URL":"https:\/\/doi.org\/10.1007\/s10875-023-01488-6","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,19]]},"assertion":[{"value":"22 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental work was performed under protocols approved by the Institutional Review Board (IRB) of the Institution (imas12), after written informed consent for publication of clinical and immunological information of the patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"All participants provided written informed consent to participate.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All participants have consented to publication of their data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}